Skip to main content

Healthcare

Do the New Obesity Drugs Pay for Themselves?

Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new study co-authored by Yale SOM’s Jason Abaluck suggests that other health expenses may actually increase over the first couple years of treatment.

Wegovy autoinjectors in a case
  • How Is the Pharmaceutical Industry Responding to COVID-19?

    As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.

    Dr. Sonia Macieiewski and Dr. Nita Patel at a Novavax lab in Rockville, Maryland, on March 20. Photo: Andrew Caballero-Reynolds/AFP via Getty Images.
  • Why Isolating Older Americans Would Be a Huge Mistake in Fighting the Coronavirus

    In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.

    Empty streets in New York City on March 22. Photo: Tayfun Coskun/Anadolu Agency via Getty Images.
  • Why the WHO Was Afraid of Crying ‘Pandemic’

    Yale SOM’s Saed Alizamir, with Francis de Véricourt of ESMT and Shouqiang Wang of the University of Texas at Dallas, recently published a study that uses game theory to play out the tradeoffs that the WHO and other public agencies face as they try to give timely warnings while maintaining their credibility.

    Bruce Aylward, assistant director general of the World Health Organization, at a press conference in Beijing on February 24, 2020. Photo: Kyodo News via Getty Images.
  • How Should the U.S. Government Respond to COVID-19?

    On March 12, a group of public health experts assembled by Yale SOM’s Dr. Howard Forman released a proposal for a set of emergency public health, healthcare, and emergency support measures to respond to the growing COVID-19 outbreak.

    Federal officials testifying about the response to COVID-19 at a House Oversight Committee hearing on March 12, 2020. Photo: Sarah Silbiger/Bloomberg via Getty Images.
  • Suzanne Lagarde ’14 on Giving Back

    We talked with Dr. Suzanne Lagarde ’14, CEO of Fair Haven Community Health Care, about delivering healthcare to those who need it most.

    Dr. Suzanne Lagarde at Fair Haven Community Healthcare
  • Coronavirus Update: How Far Has the Virus Spread and What’s Next?

    Increased testing capacity is key to unlocking greater understanding of COVID-19 and learning how to slow its spread, according to Professor Howard Forman.

    Coronavirus emerging from the surface of a cell.
  • Is the U.S. Healthcare System Ready for Coronavirus?

    We asked Yale’s Howard P. Forman, a practicing radiologist and expert in healthcare management, what’s likely to happen with coronavirus in coming days and whether the U.S. healthcare system is prepared.

    Coronavirus testing kit
  • New Outbreaks of Coronavirus Can Be Halted with Isolation Measures, According to Study

    Yale SOM’s Edward Kaplan used early reports out of Wuhan to evaluate the likely effectiveness of common tactics, such as isolation of patients and quarantine, in keeping the disease from spreading in new regions.

    A deserted train station in Wuhan, China, on January 23, 2020. Photo: Hector Retamal/AFP via Getty Images.
  • Study: Pharmaceutical Ads Drive Prescriptions—And Save Us All Money

    Yale SOM’s Michael Sinkinson found that fewer people get life-savings statins during primary season, when pharmaceutical ads are displaced by political ads.

    Illustration of a pharmaceutical ad on a TV
  • Are Electronic Health Records Useful Yet? 

    The story of EHRs serves as a prelude to what we’re experiencing today in almost every facet of our lives: a utopian promise of ubiquitous data tempered by technical challenges and concerns over privacy.

    Javier Larrea/Alamy Stock Photo